DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Gastro-Oesophageal Reflux Disease Pipeline Highlights - 2017" drug pipelines to their offering.
Gastro-Oesophageal Reflux Disease Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Gastro-Oesophageal Reflux Disease market. It covers emerging therapies for Gastro-Oesophageal Reflux Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Gastro-Oesophageal Reflux Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Gastro-Oesophageal Reflux Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Gastro-Oesophageal Reflux Disease pipeline products by the company.
Short-term Launch Highlights:
Find out which Gastro-Oesophageal Reflux Disease pipeline products will be launched in the US and Ex-US till 2020.
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/4vnmp6/gastrooesophageal